| Apimostinel |
NRX-1074 |
1421866-48-9 |
| MM-102 |
MM-102 |
1417329-24-8 |
| Methyl 4-fluoro-1-Methyl-5-(phenylaMino)-1H-benzo[d]iMidazole-6-carboxylate |
4-氟-1-甲基-5-(苯基氨基)-1H-苯并[D]咪唑-6-羧酸甲酯 |
1415564-48-5 |
| PF-05085727 |
PF-05085727 |
1415637-72-7 |
| 2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]- |
无中文名称 |
1402086-20-7 |
| Cdc7-IN-1 |
CDC7-IN-1 (COMPOUND 13) |
1402055-25-7 |
| BI 882370 |
BI 882370 |
1392429-79-6 |
| (2R)-Octyl-α-hydroxyglutarate |
(2R)-辛基-Α-羟基戊二酸酯 |
1391194-67-4 |
| (2S)-Octyl-α-hydroxyglutarate |
(2S)-OCTYL-伪-HYDROXYGLUTARATE |
1391194-64-1 |
| ComplementfactorD-IN-1 |
1386455-76-0 |
1386455-76-0 |
| Methanesulfonic acid, 1,1,1-trifluoro-, compd. with 4,5-dihydro-4,4-dimethyl-2-(methylthio)oxazole (1:1) |
1,1,1-三氟-甲磺酸化合物与 4,5-二氢-4,4-二甲基-2-(甲硫基)恶唑 (1:1) |
1384956-50-6 |
| BMS-986020 sodium |
BMS-986020 SODIUM |
1380650-53-2 |
| CCR2 antagonist 3 |
CCR2 ANTAGONIST 3 |
1380100-86-6 |
| Lambrolizumab |
派姆单抗 |
1374853-91-4 |
| Ubrogepant |
乌布吉泮 |
1374248-77-7 |
| MK-8031 |
UBROGEPANT |
1374248-81-3 |
| 2-Pyridinamine, 3-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]- |
(S)-CRIZOTINIB |
1374356-45-2 |
| (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate |
TALAZOPARIB TOSYLATE |
1373431-65-2 |
| Gemigliptin |
吉格列汀酒石酸盐 |
1374639-74-3 |
| [4-[Bis(4-chlorophenyl)methyl]piperazin-1-yl]-(5-methyl-4-nitro-1,2-oxazol-3-yl)methanone |
[4-[Bis(4-chlorophenyl)methyl]piperazin-1-yl]-(5-methyl-4-nitro-1,2-oxazol-3-yl)methanone |
1360705-96-9 |
